Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.
Berapa harga saham Tiziana Life Sciences hari ini?▼
Harga saat ini dari TLSA.BOATS adalah $1.3 USD — naik sebesar +0% dalam 24 jam terakhir. Pantau kinerja harga saham Tiziana Life Sciences lebih dekat di grafik.
Apa simbol saham Tiziana Life Sciences?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Tiziana Life Sciences diperdagangkan dengan simbol TLSA.BOATS.
Kapan tanggal laporan keuangan berikutnya dari Tiziana Life Sciences?▼
Tiziana Life Sciences akan merilis laporan keuangan berikutnya pada Juni 18, 2026.
Berapa jumlah karyawan Tiziana Life Sciences?▼
Per April 01, 2026, perusahaan memiliki 9 karyawan.
Tiziana Life Sciences berada di sektor apa?▼
Tiziana Life Sciences beroperasi di sektor Health Care.
Kapan Tiziana Life Sciences menyelesaikan split saham?▼
Tiziana Life Sciences belum melakukan split saham baru-baru ini.
Di mana kantor pusat Tiziana Life Sciences?▼
Kantor pusat Tiziana Life Sciences berlokasi di London, GB.